Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;40(4):e0822.
doi: 10.1097/RTI.0000000000000822.

Reduction of Streak Artifacts in the Superior Vena Cava for Better Visualization of Mediastinal Structures Through Virtual Monoenergetic Reconstructions Using a Photon-counting Detector Computed Tomography

Greta Thater  1 , Isabel Frerichs  1 , Sylvia Büttner  2 , Stefan O Schoenberg  1 , Matthias Froelich  1 , Isabelle Ayx  1
Affiliations

Reduction of Streak Artifacts in the Superior Vena Cava for Better Visualization of Mediastinal Structures Through Virtual Monoenergetic Reconstructions Using a Photon-counting Detector Computed Tomography

Greta Thater et al. J Thorac Imaging. .

Abstract

Purpose: Computed tomography (CT) is crucial in oncologic imaging for precise diagnosis and staging. Beam-hardening artifacts from contrast media in the superior vena cava can degrade image quality and obscure adjacent structures, complicating lymph node assessment. This study examines the use of virtual monoenergetic reconstruction with photon-counting detector CT (photon-counting CT) to mitigate these artifacts.

Materials and methods: The retrospective study included 50 patients who underwent thoracoabdominal scans. Virtual monoenergetic reconstructions at nine keV levels (60 to 140 keV) were analyzed for Hounsfield Unit (HU) stability, image noise, and artifact index in various regions of interest (ROIs): mediastinal adipose tissue (ROI 1 to 3) and vascular stations (ROI 4 to 6) were compared with reference tissue (ROI 7 to 8). The diagnostic image quality of the keV levels was assessed using a 5-point Likert Scale.

Results: Lower keV values (60 to 80) exhibited higher image noise and lower HU stability in mediastinal adipose tissue compared with higher energies, with optimal noise reduction observed at 130 keV (ROI 1 to 3). HU stability in vascular structures (ROI 4 to 6) significantly improved above 80 keV, with the best performance at 140 keV. Artifact levels decreased progressively from 60 to 140 keV. Visually, keV levels of 110 keV (96% Likert ≥4) and 120 keV (60% Likert 4) were rated most diagnostically valuable, consistent with technical findings.

Conclusion: Virtual monoenergetic reconstructions with photon-counting CT effectively reduce beam-hardening artifacts near the superior vena cava, enhancing the visualization of lymph nodes and adjacent structures. This technology advances oncologic imaging by improving diagnostic accuracy in areas previously affected by artifact-related image degradation.

Keywords: artifact reduction; oncologic imaging; photon-counting detector computed tomography; virtual monoenergetic imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

References

    1. Hsin Feng S, Su-Tso Y. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations. Diagn Interv Radiol. 2019;25:270–279.
    1. Beigelman-Aubry C, Dunet V, Brun A-L. CT imaging in pre-therapeutic assessment of lung cancer. Diagn Interv Imaging. 2016t;97:973–989.
    1. Zhanga LJ, Yangb GF, Wuc SY, et al. Dual-energy CT imaging of thoracic malignancies. Cancer Imaging. 2013;13:81–91.
    1. Li Q, Li X, Li XY, et al. Spectral CT in lung cancer: usefulness of iodine concentration for evaluation of tumor angiogenesis and prognosis. AJR Am J Roentgenol. 2020;215:595–602.
    1. Yang H, Fan H-X, Song L-H, et al. Relationship between contrast-enhanced CT and clinicopathological characteristics and prognosis of non-small cell lung cancer. Oncol Res Treat. 2017;40:516–522.